Congenital anomalies after prenatal ecstasy exposure Original Research Article

Prospective follow-up of 136 babies exposed to ecstasy in utero indicated that the drug may be associated with a significantly increased risk of congenital defects (15·4% [95% CI 8·2–25·4]). Cardiovascular anomalies (26 per 1000 livebirths [3·0–9·0]) and musculoskeletal anomalies (38 per 1000 [8·0–109·0]) were predominant.